[MATRIX] YoY Cumulative Quarter Result on 31-Dec-2014

Stock
[MATRIX] MATRIX CONCEPTS HOLDINGS BHD
Announcement Date
12-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Dec-2014
Profit Trend
QoQ- 44.53%
YoY- 19.19%
Quarter Report
Latest QR
Upcoming QR
MATRIX's Result
MATRIX's Financial Summary
View:
Show?
Cumulative Result
31/12/14 CAGR
Revenue 598,842 -
PBT 244,586 -
Tax -62,350 -
NP 182,236 -
-
NP to SH 182,236 -
-
Tax Rate 25.49% -
Total Cost 416,606 -
-
Net Worth 541,484 -
Dividend
31/12/14 CAGR
Div 70,953 -
Div Payout % 38.93% -
Equity
31/12/14 CAGR
Net Worth 541,484 -
NOSH 373,437 -
Ratio Analysis
31/12/14 CAGR
NP Margin 30.43% -
ROE 33.65% -
Per Share
31/12/14 CAGR
RPS 160.36 -
EPS 39.90 -
DPS 19.00 -
NAPS 1.45 -
Adjusted Per Share Value based on latest NOSH - 455,846
31/12/14 CAGR
RPS 47.88 -
EPS 14.57 -
DPS 5.67 -
NAPS 0.4329 -
Price Multiplier on Financial Quarter End Date
31/12/14 CAGR
Date 31/12/14 -
Price 2.70 -
P/RPS 1.68 -
P/EPS 5.53 -
EY 18.07 -
DY 7.04 -
P/NAPS 1.86 -
Price Multiplier on Announcement Date
31/12/14 CAGR
Date 12/02/15 -
Price 2.90 -
P/RPS 1.81 -
P/EPS 5.94 -
EY 16.83 -
DY 6.55 -
P/NAPS 2.00 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment